Literature DB >> 34092588

Relationships between alexisomia and the presence of latent trigger points in the upper trapezius of healthy volunteers.

Hideaki Hasuo1, Mariko Shimazu1, Ryo Sakamoto2, Hisaharu Shizuma1, Miki Nakura2, Takakazu Oka3.   

Abstract

BACKGROUND: Alexisomia is characterized by difficulties in the awareness and expression of somatic feelings. Trigger points are classified into two types, active and latent, according to the presence or absence of identifying spontaneous pain.
OBJECTIVE: We aimed to examine the association between alexisomia and the presence of latent trigger points (LTrPs) in the upper trapezius of healthy volunteers.
METHODS: This study was designed as a cross-sectional survey. A correlation analysis between the Shitsu-Taikan-Sho Scale (STSS) and LTrPs was performed on 154 healthy volunteers. The LTrP odds ratio for healthy volunteers with alexisomia was selected as the primary endpoint.
RESULTS: LTrPs were seen in the upper trapezius of 82 healthy volunteers (53.2%). There was no significant difference between the LTrP and non-LTrP groups in STSS total score (p= 0.11). However, there was a significant difference between them in STSS difficulty of identifying bodily feelings (DIB) score (p= 0.03). In the alexisomic versus non-alexisomic groups, the LTrP odds ratio for STSS total score was 2.30 (95% confidence interval [CI] 1.03-5.10) and for STSS DIB score, 2.08 (95% CI 1.05-4.11).
CONCLUSIONS: In STSS DIB in particular, alexisomia was associated with the presence of LTrP in the upper trapezius of healthy volunteers.

Entities:  

Keywords:  Latent trigger point; alexisomia; difficulty in identifying bodily feelings; over-adaptation; upper trapezius

Mesh:

Year:  2022        PMID: 34092588     DOI: 10.3233/BMR-200068

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  1 in total

1.  Effects of practicing yoga on alexisomia: an open-label trial.

Authors:  Takakazu Oka; Battuvshin Lkhagvasuren
Journal:  Biopsychosoc Med       Date:  2022-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.